Pharmabiz

CDSCO declares 240 drug samples as NSQs, three as spurious in January

CDSCO declares 240 drug samples as NSQs, three as spurious in January: Our Bureau, New Delhi Saturday, February 21, 2026, 13:45 Hrs [IST] The Central Drugs Standard Control Organi ...
Pharmabiz

Karl Landsteiner University study shows artifacts in inner ear become more pronounced when head is tilted back and less when chin is tilted down

Karl Landsteiner University study shows artifacts in inner ear become more pronounced when head is tilted back and less when chin is tilted down: Krems, Austria Saturday, February ...
Pharmabiz

Bavarian Nordic receives USD 22.5 million contract for its Mpox and Smallpox vaccine from Government of Canada

Bavarian Nordic receives USD 22.5 million contract for its Mpox and Smallpox vaccine from Government of Canada: Copenhagen, Denmark Saturday, February 21, 2026, 13:00 Hrs [IST] Ba ...
Pharmabiz

Daiichi Sankyo appoints John Tsai, MD as global head of R&D

Tokyo Saturday, February 21, 2026, 12:30 Hrs [IST] Daiichi Sankyo Company, Limited has appointed John Tsai, MD to succ ...
Pharmabiz

Merck announces positive new data for Enflonsia for infants and children under 2 years of age at increased risk for severe RSV disease over two RSV seasons

Merck announces positive new data for Enflonsia for infants and children under 2 years of age at increased risk for severe RSV disease over two RSV seasons: Rahway, New Jersey Sat ...
Pharmabiz

US FDA accepts Roche’s NDA for giredestrant in ESR1-mutated, ER-positive advanced breast cancer

US FDA accepts Roche’s NDA for giredestrant in ESR1-mutated, ER-positive advanced breast cancer: Basel Saturday, February 21, 2026, 11:00 Hrs [IST] Roche announced that the Unit ...
Pharmabiz

EMA validates Type II Variation marketing application for Enhertu as post-neoadjuvant treatment for patients with HER2 positive earlybreast cancer

EMA validates Type II Variation marketing application for Enhertu as post-neoadjuvant treatment for patients with HER2 positive earlybreast cancer: Tokyo Saturday, February 21, 20 ...
Pharmabiz

IBA, Shreeji sign multi-site agreement for cyclotrons to expand PET radiopharmaceutical manufacturing across India

IBA, Shreeji sign multi-site agreement for cyclotrons to expand PET radiopharmaceutical manufacturing across India: Louvain-la-Neuve, Belgium Saturday, February 21, 2026, 09:00 Hr ...
Pharmabiz

Maharashtra FDA, CDSCO jointly conduct 64 risk-based inspections between April 1, 2025 & Jan 31, 2026

Maharashtra FDA, CDSCO jointly conduct 64 risk-based inspections between April 1, 2025 & Jan 31, 2026: Shardul Nautiyal, Mumbai Saturday, February 21, 2026, 08:00 Hrs [IST] In ord ...
Pharmabiz

Indian healthcare sees point-of-care diagnostics to propel speed in clinical decision-making

Indian healthcare sees point-of-care diagnostics to propel speed in clinical decision-making: Nandita Vijayasimha, Bengaluru Saturday, February 21, 2026, 08:00 Hrs [IST] Point-of- ...
Pharmabiz

Pharmacist associations hail Madras HC order for online pharmacy council elections

Pharmacist associations hail Madras HC order for online pharmacy council elections: Peethaambaran Kunnathoor, Chennai Saturday, February 21, 2026, 08:00 Hrs [IST] Professional pha ...
Pharmabiz

Zealand Pharma announces positive phase 1a top-line results with Kv1.3 channel blocker ZP9830

Zealand Pharma announces positive phase 1a top-line results with Kv1.3 channel blocker ZP9830: Copenhagen, Denmark Friday, February 20, 2026, 18:00 Hrs [IST] Zealand Pharma A/S, a ...